Connect with us

Corona

Need of the hour is to manufacture sanitisers over deodorants – SALMAN KHAN

Published

on

Salman took to Twitter, where he shared a video he said: “Ek brand launch kya hai haali main FRSH… Behetareen hai.. Pahele hum deodorants start Karne wale the… Lekin need of the hour yeh hai sanitisers start Karna. such dino ke baad (first we thought of brining out deodorants but the need of the hour is sanitisers).”

He captioned the video: “Launching my new grooming & personal care brand FRSH! @FrshGrooming Yeh hai aapka, mera, hum sabka brand jo layega aap tak behtareen products. Sanitizers aa chuke hain, jo milenge aapko yaha http://frshworld.com Toh try karo! @FrshGroomingko follow karo! #RahoFrshRahoSafe.”

According to Salman”s frshworld.com, a 100 ml bottle of sanitiser costs Rs 50 and a 500 ml bottle of sanitiser costs Rs 250. A combo pack of 10 bottled consisting of 100 ml costs Rs. 400.

People trapped in India can get permission to fly out this way

 

Corona

Pneumonia vaccine may reduce impact of COVID-19: University of Melbourne study

Published

on

Pneumonia vaccines can potentially reduce the impact of viruses such as Covid-19, said researchers, adding that it has reduced illness and death in patients with pneumonia, serious lung conditions and rotavirus, a common disease which causes severe diarrhoea and vomiting.
The University of Melbourne-led research team, which worked with the Fiji Ministry of Health and Medical Services, said the results underline the importance of vaccines and how they can potentially reduce the impact of viruses such as Covid-19.
Published in the journal ‘Lancet Regional Health – Western Pacific’, the first study looked at Fiji’s national rotavirus vaccine programme five years after it became the first independent Pacific island country to introduce the vaccine in 2012.
Advertisement

According to the researchers, rotavirus is severely contagious and the most common cause of diarrhoeal disease among infants and young children. It can even cause death in extreme cases.
After taking the vaccine, morbidity and mortality due to rotavirus and all-cause diarrhoea in Fiji fell in those aged two months to 55 years. Rotavirus diarrhoea admissions at the largest hospital among children aged under five fell by 87 per cent.
These reductions were most likely due to the vaccine as rotavirus diarrhoeal outbreaks remained blunted for the five years after vaccine introduction.
Advertisement

At the same time, in 2012, the Fiji government introduced a routine infant immunisation schedule for ten-valent pneumococcal conjugate (PCV10) vaccine using three primary doses and no booster dose.
Published in ‘The Lancet Global Health’, this second study looked at hospital admission rates for children with pneumonia at three Fiji public tertiary hospitals.
Five years after the vaccine was introduced, hospital admissions for all-cause pneumonia had fallen for children aged 24-59 months. Mortality was down by 39 per cent among children aged two to 24 months who were admitted to hospitals with all-case pneumonia, bronchiolitis and asthma.
Advertisement

The study showed the effect of PCV10 vaccine and supported its introduction for children in other low and middle-income countries in that region.
“These results provide supportive evidence of the probable benefits of PCV10 in reducing pneumonia in children in Fiji,” said study lead researcher Fiona Russell from the Murdoch Children’s Research Institute and the University of Melbourne.

Continue Reading

Trending